CASR and central nervous system cancer: In this study, we found that NPS‐2143, a calcium‐sensing receptor (CASR) antagonist, could inhibit the proliferation of glioma cells and induce cell cycle arrest and apoptosis by suppressing autophagy through mediating the AKT–mTOR pathway.